Fundz

Smartlens, Inc. raises $5.2M in bridge funding, led by Ambit Health Ventures, to advance FDA clearance for innovative glaucoma management devices.

PRIVATEOct 14, 2025

Amount Raised

$5.2 Million

Round Type

Funding Round

Mountain ViewManufacturingInformation TechnologyBiotechnologyHealth CareTherapeutics

Investors

Graphene VenturesBoutique Venture PartnersHarvard Business School Alumni Angels GNYAmbit Health Ventures

Description

Smartlens, Inc. closed a $5.2M bridge funding round to support its next-generation glaucoma management devices. The round was led by Ambit Health Ventures, with participation from Graphene Ventures, Boutique Venture Partners, and Harvard Business School Alumni Angels GNY. The funds will be used to advance the FDA clearance process and prepare for market launch

Who else raised in Therapeutics and Manufacturing around the same time

Companies in the same sectors as Smartlens that raised within 45 days of this round, from Fundz verified event records.

  • SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
  • Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
  • Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
  • Verrica raised $50M on November 25, 2025.
  • MindImmune Therapeutics raised $10M (Series A) on November 24, 2025.
  • FibroBiologics raised $1.5M on November 24, 2025.

Who to call at Smartlens, and when

A new round usually means Smartlens is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Smartlens raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Smartlens, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Smartlens. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Smartlens

Location

Mountain View, California, United States

About

Smartlens is developing novel solutions for managing glaucoma and other anterior segment eye diseases. We are transforming traditional eye care into personalized, proactive disease management through our technologies addressing unmet needs in eye care since the 1950s, with solutions designed for millions of patients worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Smartlens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Smartlens's next move

See what Strategic adds

Smartlens raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.